Biogen Inc.
Explore Biogen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Biogen Inc.
Explore Biogen Inc.
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2023 Revenue
$9.7B
▼ 4.3% vs FY2022 ($10.2B)
Source: Annual report / company filing
Biogen Inc. reported $9.7B in revenue for fiscal year 2023. This represents a decline of 4.3% compared to the 2022 figure of $10.2B. In 2024, revenue declined to $9.6B.
Revenue slipped 4.3% to $9.73 billion in 2023 as continued Tecfidera generic competition and Spinraza softness outweighed the early launch of Skyclarys for Friedreich's ataxia.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $9.9B | — | +2.8% |
| FY2024 | $9.6B | $1.2B | -1.1% |
| FY2023 | $9.7B | — | -4.3% |
| FY2022 | $10.2B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.